⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNRX News
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
globenewswire.com
QNRX
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
globenewswire.com
QNRX
Octave Bioscience Accelerates Precision Neurology Momentum, Appoints Zachary Fernandes as VP of Business Development to Scale Strategic Partnerships
businesswire.com
QNRX
MBIO
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
businesswire.com
TMO
ABBV
DHR
ILMN
NVO
QNRX
XBIO
Form 8-K
sec.gov
QNRX
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
globenewswire.com
QNRX
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
globenewswire.com
QNRX
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
globenewswire.com
QNRX
Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
globenewswire.com
QNRX